98 related articles for article (PubMed ID: 10727064)
1. Hepatic osteodystrophy in elderly: role of insulin-like growth factor-I and osteocalcin.
Cotrozzi G; Giusti S; Bini S; Carloni V; Mazzocca A; Frati M
J Endocrinol Invest; 1999; 22(10 Suppl):88-9. PubMed ID: 10727064
[No Abstract] [Full Text] [Related]
2. [Endocrine-metabolic aspects of rarefying osteopathy of patients with cirrhosis].
Grandi M; Pederzoli S; Sacchetti C; Maietta A; Bonati ME; Riva P
Recenti Prog Med; 1991; 82(7-8):363-6. PubMed ID: 1947398
[TBL] [Abstract][Full Text] [Related]
3. [Hepatic osteodystrophy in our environment].
Suárez Jiménez MI; Vergara de Campos A; Rico Irles J
Rev Clin Esp; 1985 Mar; 176(4):177-81. PubMed ID: 4001466
[No Abstract] [Full Text] [Related]
4. The use of vitamin K may be a good choice for microgravity-induced bone disorder.
Sugiyama T; Kawai S
J Bone Miner Res; 2001 Apr; 16(4):794-5. PubMed ID: 11316009
[No Abstract] [Full Text] [Related]
5. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis.
Chlebna-Sokol D; Rusinska A
Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767
[TBL] [Abstract][Full Text] [Related]
6. [Hepatic and biliary involvements in systemic diseases].
Cacoub P; Valla D; Chemlal K; Tazi Z; Lunel-Fabiani F; Godeau P
Gastroenterol Clin Biol; 1994; 18(5):414-23. PubMed ID: 7813856
[No Abstract] [Full Text] [Related]
7. [Organic nephropathies in patients with liver diseases].
Amoedo ML; Montoliu J
Gastroenterol Hepatol; 1996 Mar; 19(3):167-77. PubMed ID: 8991663
[No Abstract] [Full Text] [Related]
8. Osteodystrophy in patients with chronic hepatitis and liver cirrhosis.
Tsuneoka K; Tameda Y; Takase K; Nakano T
J Gastroenterol; 1996 Oct; 31(5):669-78. PubMed ID: 8887033
[TBL] [Abstract][Full Text] [Related]
9. Clinical uses of insulin-like growth factor I.
Hussain MA; Froesch ER
Adv Endocrinol Metab; 1995; 6():143-65. PubMed ID: 7671094
[No Abstract] [Full Text] [Related]
10. Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study.
Mazziotti G; Sorvillo F; Morisco F; Carbone A; Rotondi M; Stornaiuolo G; Precone DF; Cioffi M; Gaeta GB; Caporaso N; Carella C
Cancer; 2002 Dec; 95(12):2539-45. PubMed ID: 12467068
[TBL] [Abstract][Full Text] [Related]
11. Oval cells in hepatitis B virus-positive and hepatitis C virus-positive liver cirrhosis: histological and ultrastructural study.
Sun C; Jin XL; Xiao JC
Histopathology; 2006 Apr; 48(5):546-55. PubMed ID: 16623780
[TBL] [Abstract][Full Text] [Related]
12. Clinical benefits of biochemical markers of bone turnover in Egyptian children with chronic liver diseases.
Mahdy KA; Ahmed HH; Mannaa F; Abdel-Shaheed A
World J Gastroenterol; 2007 Feb; 13(5):785-90. PubMed ID: 17278204
[TBL] [Abstract][Full Text] [Related]
13. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease.
Diamond TH; Stiel D; Lunzer M; McDowall D; Eckstein RP; Posen S
Gastroenterology; 1989 Jan; 96(1):213-21. PubMed ID: 2783312
[TBL] [Abstract][Full Text] [Related]
14. Serum concentrations of insulin-like growth factor-I (IGF-I) in patients with liver cirrhosis.
Vyzantiadis T; Theodoridou S; Giouleme O; Harsoulis P; Evgenidis N; Vyzantiadis A
Hepatogastroenterology; 2003; 50(51):814-6. PubMed ID: 12828091
[TBL] [Abstract][Full Text] [Related]
15. Osteoblast dysfunction in male idiopathic osteoporosis.
Pernow Y; Granberg B; Sääf M; Weidenhielm L
Calcif Tissue Int; 2006 Feb; 78(2):90-7. PubMed ID: 16467976
[TBL] [Abstract][Full Text] [Related]
16. Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: not just a cholestatic problem.
Carey EJ; Balan V; Kremers WK; Hay JE
Liver Transpl; 2003 Nov; 9(11):1166-73. PubMed ID: 14586877
[TBL] [Abstract][Full Text] [Related]
17. [Hepato-biliary and pancreatic disease and osteodystrophy].
Imaeda K; Nojiri S
Clin Calcium; 2009 Sep; 19(9):1275-80. PubMed ID: 19721198
[TBL] [Abstract][Full Text] [Related]
18. [Vascular purpura in patients with chronic diffuse hepatic diseases].
Russkikh AV; Kozlovskaia LV; Krivosheev OG; Mukhin NA
Klin Med (Mosk); 2005; 83(10):45-8. PubMed ID: 16320846
[TBL] [Abstract][Full Text] [Related]
19. Biliary intraepithelial neoplasia in patients without chronic biliary disease: analysis of liver explants with alcoholic cirrhosis, hepatitis C infection, and noncirrhotic liver diseases.
Wu TT; Levy M; Correa AM; Rosen CB; Abraham SC
Cancer; 2009 Oct; 115(19):4564-75. PubMed ID: 19670455
[TBL] [Abstract][Full Text] [Related]
20. [Growth factors in assessing hepatic fibrosis in patients with chronic hepatitis C].
Ivkova AN; Il'chenko LIu; Kushlinskiĭ NE; Petrenko NV; Storozhakov GI
Eksp Klin Gastroenterol; 2008; (5):42-6. PubMed ID: 19145916
[No Abstract] [Full Text] [Related]
[Next] [New Search]
